Total Payments
$2,642
2024 Payments
$249.94
Companies
11
Transactions
45
Medicare Patients
2,241
Medicare Billing
$205,575
Payment Breakdown by Category
Food & Beverage$1,584 (60.0%)
Travel$1,057 (40.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,584 | 40 | 60.0% |
| Travel and Lodging | $1,057 | 5 | 40.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation of the Americas | $1,107 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $531.18 | 12 | $0 (2023) |
| United Therapeutics Corporation | $373.05 | 3 | $0 (2024) |
| Genentech USA, Inc. | $343.79 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $139.39 | 9 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $53.60 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $39.88 | 2 | $0 (2022) |
| Mylan Specialty L.P. | $15.37 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $15.28 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $11.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.94 | 2 | United Therapeutics Corporation ($249.94) |
| 2023 | $232.83 | 2 | United Therapeutics Corporation ($123.11) |
| 2022 | $15.20 | 1 | AstraZeneca Pharmaceuticals LP ($15.20) |
| 2021 | $82.03 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($82.03) |
| 2020 | $94.05 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($94.05) |
| 2019 | $320.25 | 3 | Genentech USA, Inc. ($223.42) |
| 2018 | $165.85 | 10 | GlaxoSmithKline, LLC. ($78.55) |
| 2017 | $1,481 | 25 | Olympus Corporation of the Americas ($1,107) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $124.97 | General |
| 07/23/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $124.97 | General |
| 11/09/2023 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $123.11 | General |
| 06/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $109.72 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Respiratory | ||||||
| 03/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV, OFEV | Food and Beverage | In-kind items and services | $82.03 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $94.05 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $123.27 | General |
| 10/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $96.83 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $100.15 | General |
| 10/30/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 07/11/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Respiratory | ||||||
| 06/29/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2018 | Mylan Specialty L.P. | Dymista (Drug), Perforomist | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Respiratory and Allergy | ||||||
| 06/15/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Respiratory | ||||||
| 04/06/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
| 01/10/2018 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2017 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $10.81 | General |
| 10/04/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2017 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 462 | 604 | $98,254 | $38,677 |
| 2022 | 11 | 514 | 697 | $110,472 | $44,496 |
| 2021 | 15 | 653 | 893 | $161,716 | $68,720 |
| 2020 | 14 | 612 | 802 | $146,297 | $53,682 |
Total Patients
2,241
Total Services
2,996
Medicare Billing
$205,575
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 221 | $38,919 | $15,408 | 39.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 84 | $17,304 | $7,671 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 116 | $13,301 | $5,491 | 41.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 20 | $8,796 | $3,356 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $9,793 | $2,922 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,006 | $1,842 | 36.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $2,956 | $1,246 | 42.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 14 | 15 | $684.84 | $262.65 | 38.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 27 | 27 | $696.50 | $202.00 | 29.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 27 | 27 | $502.04 | $181.36 | 36.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 12 | 12 | $296.64 | $94.40 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 282 | $46,365 | $19,967 | 43.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 35 | $15,393 | $5,940 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $14,233 | $5,025 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 78 | 93 | $9,611 | $4,091 | 42.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 60 | $8,590 | $3,429 | 39.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 37 | $7,622 | $3,026 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $5,970 | $2,117 | 35.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 32 | 32 | $824.00 | $255.42 | 31.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 14 | 15 | $800.31 | $250.52 | 31.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 32 | 32 | $593.28 | $221.16 | 37.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 19 | 19 | $469.68 | $173.40 | 36.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 39 | 95 | $40,988 | $18,123 | 44.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 228 | $37,096 | $17,265 | 46.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 67 | 156 | $31,314 | $14,350 | 45.8% |
About Dr. Yasmin Mahal, DO
Dr. Yasmin Mahal, DO is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710146485.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yasmin Mahal, DO has received a total of $2,642 in payments from pharmaceutical and medical device companies, with $249.94 received in 2024. These payments were reported across 45 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,584).
As a Medicare-enrolled provider, Mahal has provided services to 2,241 Medicare beneficiaries, totaling 2,996 services with total Medicare billing of $205,575. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Biddeford, ME
- Active Since 06/06/2008
- Last Updated 09/20/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1710146485
Products in Payments
- EVIS EXERA (Device) $1,107
- OFEV (Drug) $405.25
- STIOLTO (Drug) $101.96
- NUCALA (Biological) $50.98
- UTIBRON (Drug) $40.29
- TRELEGY ELLIPTA (Drug) $27.57
- BEVESPI AEROSPHERE (Drug) $24.68
- STIOLTO RESPIMAT (Drug) $23.97
- ANORO (Drug) $20.59
- Dymista (Drug) $15.37
- XOLAIR (Biological) $15.28
- TEZSPIRE (Biological) $15.20
- LONHALA MAGNAIR (Drug) $13.31
- ASMANEX (Drug) $11.74
- Prolastin-C (Biological) $11.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Dr. Peter Rubin, M.d, M.D
Internal Medicine — Payments: $31,481
Internal Medicine $31,481
Steven Cutone, D.o, D.O
Internal Medicine — Payments: $2,606
Internal Medicine $2,606
Jennifer Cutone, M.d, M.D
Internal Medicine — Payments: $2,262
Internal Medicine $2,262
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Internal Medicine $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712
Internal Medicine $1,712
Dr. Maureen Lee, D.o, D.O
Internal Medicine — Payments: $1,636
Internal Medicine $1,636